QA148959 Quoted To: Cody Wolf University of VirginiaPLEC - Human shRNA lentiviral particles (4… and 1 more item

OriGene Technologies Inc was awarded a contract by the University of Virginia on October 10, 2026, with a cumulative value of $1,831.00. The contract number is A207_PO-0455537-V3. The primary deliverable consists of Human short hairpin ribonucleic acid (shRNA) lentiviral particles provided through the PLEC (Plasmid-based Lentiviral Expression Construct) system. The order specifications include four target-specific and one scramble control variant, each supplied in 0.5 milliliter volumes with a titer exceeding 10^7 transduction units per milliliter, with a quantity of 1,731 units ordered.

The contract also includes shipping costs associated with dry ice preservation, with 100 units of shipping charges incorporated into the total award value. The deliverables were directed to the designated buyer at the University of Virginia, located in Virginia. All products and services are to be delivered in accordance with the specifications outlined in the purchase order A207_PO-0455537-V3, which represents a research support agreement for molecular biology reagents and associated logistics.